MedTrace Logo

Effects of Protein Hydrolysate Supplementation Influencing Strength Recovery and Expression of Muscle Damage Markers Post-exercise

NCT05159375 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2023-11-21

No results posted yet for this study

Summary

A randomised placebo controlled, double-blind, 30 Volunteer trial of Elio™ administered 2.4 grams per day in assessing its effects on post-exercise strength recovery and increases in markers associated with muscle injury and exertion.

Conditions

  • Muscle Injury

Interventions

DIETARY_SUPPLEMENT

Elio

Elio™ supplementation, a protein hydrolysate derived from fava bean protein extract

OTHER

SMCC

Placebo comparator

Sponsors & Collaborators

  • Sports Surgery Clinic, Santry, Dublin

    collaborator OTHER

  • Nuritas Ltd

    lead INDUSTRY

Principal Investigators

  • Andy Franklyn-Miller · Santry Sports Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-06
Primary Completion
2022-01-22
Completion
2022-04-04

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05159375 on ClinicalTrials.gov